Metropolis Healthcare Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company is almost debt free
- Latest quarter profit grew 1157.2% YoY, showing strong momentum
- Company has consistently been profitable over the last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.89x)
- Company has been maintaining a healthy dividend payout of 54.6%
CONS
- Company has delivered a poor profit growth of 0.8% over past five years
- Total debt has risen sharply - up 32.0% year on year
- Stock is trading at 6.0x its book value
- Expensive relative to growth - PEG of 6.1
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | 8875.00 | 61.07 | 127608.88 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| MAXHEALTH | 1039.00 | 69.41 | 101126.94 | 0.19 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| MANIPALHOS | 733.10 | 108.07 | 96430.30 | 0.00 | 2434.30 | — | 30906.30 | — | 13.93 | 23.83 |
| FORTIS | 901.80 | 64.97 | 68082.13 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| ASTERDM | 766.70 | 209.71 | 66831.13 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.26 | 19.53 |
| MEDANTA | 1459.55 | 70.56 | 39243.18 | 0.03 | 157.25 | -1.09 | 1304.05 | 26.50 | 19.38 | 21.99 |
| NH | 1909.10 | 47.80 | 39014.52 | 0.24 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| KIMS | 772.75 | 158.86 | 32456.00 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| LALPATHLAB | 1916.70 | 59.37 | 32171.58 | 1.07 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| AGARWALEYE | 505.05 | 107.92 | 16011.41 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 16.14 | 27.75 |
| VIJAYA | 1498.50 | 82.32 | 15434.21 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.28 | 42.66 |
| METROPOLIS | 596.70 | 61.40 | 12378.77 | 0.84 | 568.83 | 1157.22 | 4502.15 | 1066.18 | 20.03 | 24.70 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 277 | 308 | 291 | 331 | 313 | 350 | 323 | 345 | 386 | 429 | 406 | 425 | 4,502 | |
| 214 | 234 | 226 | 251 | 235 | 260 | 251 | 283 | 296 | 321 | 311 | 317 | 3,776 | |
| Operating Profit | 63 | 75 | 65 | 80 | 79 | 90 | 72 | 62 | 90 | 108 | 95 | 108 | 726 |
| OPM % | 22.71% | 24.25% | 22.28% | 24.16% | 25.15% | 25.70% | 22.31% | 18.04% | 23.25% | 25.21% | 23.37% | 25.44% | 16.13% |
| 3 | 1 | 2 | 3 | 2 | 3 | 3 | 7 | 8 | 1 | -0 | 8 | 51 | |
| Interest | 6 | 6 | 5 | 6 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 8 | 62 |
| Depreciation | 21 | 22 | 25 | 26 | 26 | 27 | 28 | 29 | 31 | 32 | 32 | 39 | 324 |
| Profit before Tax | 39 | 48 | 37 | 51 | 51 | 61 | 42 | 36 | 61 | 71 | 57 | 70 | 777 |
| Tax % | 26.05% | 25.88% | 25.96% | 27.73% | 25.39% | 23.94% | 25.65% | 18.90% | 26.11% | 25.54% | 26.36% | 26.95% | 26.80% |
| Net Profit | 0 | 0 | 0 | 0 | 38 | 47 | 31 | 29 | 45 | 53 | 42 | 51 | 569 |
| 5.62 | 6.92 | 5.30 | 7.11 | 7.41 | 9.08 | 6.12 | 1.42 | 8.70 | 10.17 | 7.99 | 2.46 | 2.73 |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 545 | 647 | 761 | 856 | 998 | 1,228 | 1,148 | 1,208 | 1,331 | 1,646 | 5,762 | |
| 391 | 469 | 557 | 619 | 708 | 883 | 857 | 920 | 1,023 | 1,242 | 4,725 | |
| Operating Profit | 153 | 178 | 204 | 237 | 290 | 346 | 291 | 288 | 308 | 404 | 1,037 |
| OPM % | 28.18% | 27.58% | 26.79% | 27.69% | 29.04% | 28.14% | 25.35% | 23.84% | 23.16% | 24.57% | 18.00% |
| 26 | 8 | 8 | -16 | 12 | 36 | 17 | 9 | 15 | 17 | 60 | |
| Interest | 2 | 4 | 4 | 13 | 12 | 25 | 32 | 28 | 24 | 29 | 81 |
| Depreciation | 17 | 19 | 20 | 39 | 46 | 63 | 89 | 94 | 109 | 134 | 427 |
| Profit before Tax | 160 | 164 | 187 | 169 | 244 | 293 | 188 | 175 | 191 | 259 | 975 |
| Tax % | 32.93% | 31.67% | 33.74% | 24.41% | 24.96% | 26.82% | 23.52% | 26.47% | 23.76% | 26.23% | 26.70% |
| Net Profit | 107 | 112 | 124 | 128 | 183 | 215 | 143 | 128 | 146 | 191 | 715 |
| EPS | 20.35 | 20.89 | 24.02 | 25.25 | 35.79 | 41.66 | 27.81 | 24.95 | 27.99 | 9.16 | — |
| Dividend Payout % | 49.19% | 0.00% | 55.38% | 31.81% | 22.33% | 19.11% | 28.67% | 16.03% | 0.00% | 54.56% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- 12%
- 5 Years:
- 11%
- 3 Years:
- 13%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 10%
- 5 Years:
- 1%
- 3 Years:
- 10%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- -5%
- 3 Years:
- 19%
- 1 Year:
- 10%
RETURN ON EQUITY
- 10 Years:
- 23%
- 5 Years:
- 16%
- 3 Years:
- 13%
- Last Year:
- 14%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 41 |
| Minority Interest | 21 | 14 | 1 | 2 | 1 | 2 | 2 | 3 | 4 | 11 |
| 314 | 404 | 406 | 511 | 688 | 864 | 971 | 1,078 | 1,313 | 1,461 | |
| 9 | 3 | 20 | 50 | 80 | 342 | 205 | 119 | 121 | 158 | |
| Trade Payables | 36 | 35 | 43 | 85 | 111 | 103 | 94 | 99 | 126 | 129 |
| 122 | 344 | 323 | 271 | 169 | 423 | 428 | 438 | 693 | 723 | |
| Total Liabilities | 512 | 810 | 803 | 930 | 1,059 | 1,745 | 1,710 | 1,748 | 2,266 | 2,525 |
| 202 | 207 | 213 | 296 | 343 | 1,059 | 1,121 | 1,177 | 1,447 | 1,601 | |
| Capital Work in Progress | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 142 | 102 | 33 | 14 | 10 | 16 | 15 | 55 | 71 | 142 | |
| 14 | 21 | 26 | 24 | 41 | 51 | 45 | 39 | 48 | 45 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 126 | 148 | 170 | |
| Cash & Bank | 41 | 60 | 80 | 210 | 420 | 167 | 93 | 71 | 49 | 62 |
| 112 | 419 | 451 | 384 | 246 | 452 | 437 | 280 | 504 | 503 | |
| Total Assets | 512 | 810 | 803 | 930 | 1,059 | 1,745 | 1,710 | 1,748 | 2,266 | 2,525 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 153 | 162 | 158 | 279 | 306 | 336 | 299 | 264 | 263 | 351 | |
| Cash from Investing | -86 | 2 | 35 | -105 | 62 | -738 | 47 | -89 | -201 | -223 |
| Cash from Financing | -17 | -87 | -118 | -55 | -33 | 163 | -292 | -181 | -87 | -115 |
| -1 | 19 | 7 | 55 | 278 | -322 | 2 | -7 | -25 | 12 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-09 - Metropolis Healthcare Limited has informed the Exchange about allotment of 66,312 equity shares under the Metropolis-Restrictive Stock Unit Plan, 2020.
2026-09-07 - Metropolis Healthcare Limited has informed the Exchange about Other Restructuring
2026-09-02 - Metropolis Healthcare Limited has informed the Exchange about Transcript
2026-08-27 - Metropolis Healthcare Limited has informed the Exchange about Link of Recording
2026-08-27 - Metropolis Healthcare Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI Listing Regulations
2026-08-27 - Metropolis Healthcare Limited has informed the Exchange about Investor Presentation
2026-08-20 - Metropolis Healthcare Limited has informed the Exchange about disclosure under Regulation 30 of SEBI Listing Regulations
2026-08-20 - Metropolis Healthcare Limited has informed the Exchange about meeting with investors scheduled on August 27, 2026
2026-08-19 - Metropolis Healthcare Limited has submitted the Exchange a copy Scrutinizer's Report of Annual General Meeting held on August 18, 2026
News
Recent coverage and analyst commentary for METROPOLIS
Loading news…
AI Stock Analyst
Metropolis Healthcare Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account